Expanding buprenorphine access in the United States requires evidence-based decision-making that considers both the drug's potential dangers and its potential benefits. Risks associated with buprenorphine misuse and diversion highlight the need for careful, ongoing evaluation during each stage of increased access.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1073110518782935 | DOI Listing |
Publication Analysis
Top Keywords
buprenorphine mat
4
mat imperfect
4
imperfect expanding
4
expanding buprenorphine
4
buprenorphine access
4
access united
4
united states
4
states requires
4
requires evidence-based
4
evidence-based decision-making
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!